Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Followup Study for Infant Feeding Practices Study II, 41501-41502 [2011-17676]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 135 / Thursday, July 14, 2011 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Intent To Award Affordable
Care Act (ACA) Funding, EH09–907
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
This notice provides public
announcement of CDC’s intent to award
Affordable Care Act (ACA)
appropriations to the following 7
grantees: Colorado, Iowa, Kansas,
Louisiana, Minnesota, South Carolina,
and Vermont to develop and implement
their Tracking Networks. These
activities are proposed by the abovementioned grantees in their FY 2011
applications submitted under funding
opportunity EH09–907, ‘‘National
Environmental Public Health Tracking
Program—Network Implementation
(EPHT),’’ Catalogue of Federal Domestic
Assistance Number (CFDA): 93.070.
Approximately $4,920,000 in ACA
funding will be awarded to the grantees
for network expansion and
enhancement. Funding is appropriated
under the Affordable Care Act (Pub. L.
111–148), Section 4002 [42 U.S.C.
300u–11]; (Prevention and Public
Health Fund).
Accordingly, CDC adds the following
information to the previously published
funding opportunity announcement of
EH09–907:
—Authority: Sections 311 and 317(k)(2)
of the Public Health Service Act, [42
U.S.C. Sections 243 and 247b(k)(2)] as
amended, and the Patient Protection
and Affordable Care Act (ACA),
Section 4002 [42 U.S.C. 300u–11].
—CFDA #: 93.538 Affordable Care Act—
National Environmental Public Health
Tracking Program—Network
Implementation.
wreier-aviles on DSKGBLS3C1PROD with NOTICES
SUMMARY:
Award Information:
Type of Award: Non-Competing
Continuation Cooperative Agreement.
Approximate Total Current Fiscal
Year ACA Funding: $4,920,000.
Anticipated Number of Awards: 7.
Fiscal Year Funds: 2011.
Anticipated Award Date: August 1,
2011.
Application Selection Process:
Funding will be awarded to
applicants based on results from
successful past performance review.
Funding Authority:
CDC will add the ACA Authority to
that which is reflected in the published
Funding Opportunity CDC–RFA–EH09–
VerDate Mar<15>2010
14:55 Jul 13, 2011
Jkt 223001
907. The revised funding authority
language will read:
—This program is authorized under
Sections 311 and 317(k)(2) of the
Public Health Service Act, [42 U.S.C.
Sections 243 and 247b(k)(2)], as
amended, and the Patient Protection
and Affordable Care Act (ACA),
Section 4002 [42 U.S.C. 300u–11].
DATES: The effective date for this action
is the date of publication of this Notice
and remains in effect until the
expiration of the project period of the
ACA funded applications.
FOR FURTHER INFORMATION CONTACT:
Elmira Benson, Acting Deputy Director,
Procurement and Grants Office, Centers
for Disease Control and Prevention,
2920 Brandywine Road, Atlanta, GA
30341, telephone (770) 488–2802, e-mail
Elmira.Benson@cdc.gov.
SUPPLEMENTARY INFORMATION: On March
23, 2010, the President signed into law
the Affordable Care Act (ACA), Public
Law 111–148. The ACA is designed to
improve and expand the scope of health
care coverage for Americans. Cost
savings through disease prevention is an
important element of this legislation
and the ACA has established a
Prevention and Public Health Fund
(PPHF) for this purpose. Specifically,
the legislation states in Section 4002
that the PPHF is to ‘‘provide for
expanded and sustained national
investment in prevention and public
health programs to improve health and
help restrain the rate of growth in
private and public sector health care
costs.’’ The ACA and the Prevention and
Public Health Fund make improving
public health a priority with
investments to improve public health.
The PPHF states that the Secretary
shall transfer amounts in the Fund to
accounts within the Department of
Health and Human Services to increase
funding, over the fiscal year 2008 level,
for programs authorized by the Public
Health Service Act, for prevention,
wellness and public health activities
including prevention research and
health screenings, such as the
Community Transformation Grant
Program, the Education and Outreach
Campaign for Preventative Benefits, and
Immunization Programs.
The ACA legislation affords an
important opportunity to advance
public health across the lifespan and to
improve public health by supporting the
Tracking Network. This network builds
on ongoing efforts within the public
health and environmental sectors to
improve health tracking, hazard
monitoring and response capacity.
Therefore, increasing funding available
to applicants under this FOA using the
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
41501
PPHF will allow them to expand and
sustain their existing tracking networks,
utilize tracking data available on
networks for potential public health
assessments which is consistent with
the purpose of the PPHF, as stated
above, and to provide for an expanded
and sustained national investment in
prevention and public health programs.
Further, the Secretary allocated funds to
CDC, pursuant to the PPHF, for the
types of activities this FOA is designed
to carry out.
Dated: June 30, 2011.
Tanja Popovic,
Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
[FR Doc. 2011–17661 Filed 7–13–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0099]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Followup Study for
Infant Feeding Practices Study II
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by August 15,
2011.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or e-mailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–New and
title ‘‘Followup Study for Infant Feeding
Practices Study II.’’ Also include the
FDA docket number found in brackets
in the heading of this document.
FOR FURTHER INFORMATION CONTACT:
Denver Presley, Jr., Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, 301–796–
3793.
SUMMARY:
E:\FR\FM\14JYN1.SGM
14JYN1
41502
Federal Register / Vol. 76, No. 135 / Thursday, July 14, 2011 / Notices
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
Followup Study for Infant Feeding
Practices Study II (OMB Control
Number 0910—New)
I. Background
FDA is planning to conduct a survey
of the mothers who participated in the
Infant Feeding Practices Study II (IFPS
II) (Ref. 1). The IFPS II sample was
drawn from a commercial consumer
opinion panel, and so participants are
expected to be easier to re-contact than
would be the case for a random sample
of the population. Some participants
will still be panel members. The
purpose of the study is to enhance
FDA’s understanding of the associations
between infant feeding practices and
diet quality, food allergy, overweight
and obesity, and other health and
development outcomes in young
children.
The study results will be used to help
the Agency to understand the possible
role of infant feeding practices in the
development and progression of food
allergy and childhood overweight and
obesity, in addition to resistance to
infection and other health and
development outcomes. The results of
the study will not be used to develop
population estimates.
The data will be collected by a mailed
questionnaire from most respondents
and by telephone from those who do not
respond to the mailed questionnaire.
The study will focus on the following
types of information: The child’s
consumption of various food groups; the
child’s other consumption practices
(such as how often the child eats dinner
with a parent and how often he or she
eats from fast food restaurants); the
mother’s control over the child’s eating
patterns; the child’s physical activity
and time spent watching a screen (TV or
computer); the child’s sleep patterns;
extent of the child’s cognitive
stimulation at home; the child’s height
and weight; the child’s visits to a dentist
and number of cavities; number of the
child’s recent physician visits; number
of various types of infections the child
had in the past year; whether the child
has various health conditions including
digestive problems, eczema, food
allergy, respiratory allergy, attention
deficit disorder, developmental delay,
anxiety problems, depression, or
asthma; the child’s social development;
the child’s family medical history; the
mother’s height and weight, physical
activity, depression, pregnancies
subsequent to the sample child and
whether subsequent children were
breastfed, and employment conditions;
the mother’s or child’s participation in
certain government programs; and the
child’s potential exposure to certain
environmental contaminants including
cigarette smoke and pesticides.
Although all sample members were
consumer opinion panel members when
the IFPS II was conducted, many will no
longer participate on the panel.
Therefore, a demographic questionnaire
will be mailed to respondents who are
no longer a panel member to update
current demographic information.
Participation in the study is voluntary.
In the Federal Register of March 1,
2011 (76 FR 11251), FDA published a
60-day notice requesting public
comment on the proposed collection of
information. No comments were
received.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of responses per
respondent
Number of
respondents
Portion of study
Total annual
responses
Pilot study mailed questionnaire ..............................
Pilot study telephone interview ................................
Main study mailed questionnaire .............................
Main study telephone interview ...............................
Demographic questionnaire .....................................
91
9
1,538
522
1,380
1
1
1
1
1
91
9
1,538
522
1,380
Total ..................................................................
........................
........................
........................
wreier-aviles on DSKGBLS3C1PROD with NOTICES
1 There
Average burden per
response
0.42
0.42
0.33
0.33
0.08
Total hours
(25 minutes) ......
(25 minutes) ......
(20 minutes) ......
(20 minutes) ......
(5 minutes) ........
38
4
508
172
110
....................................
832
are no capital costs or operating and maintenance costs associated with this collection of information.
To refine the questionnaire used in
the study, a pilot study will be
conducted with 100 participants, 91 by
mailed questionnaire and 9 by
telephone interview. We estimate that it
will take a respondent 25 minutes (0.42
hours) to complete the survey and
debriefing questions by either method
for a total of 38 hours for the mailed and
4 hours for the interview pretest. The
sample for the pilot study will be panel
members who are mothers of 6-year-old
children and who did not participate in
the IFPS II.
All IFPS II participants who
completed at least two surveys after
their infants were born and for whom
current contact information can be
found will be sent the mailed
questionnaire. This is expected to be
about 2,562 participants. We estimate
VerDate Mar<15>2010
14:55 Jul 13, 2011
Jkt 223001
that 1,538 respondents will return it and
that it will take an average of 20 minutes
(0.33 hours) to complete the
questionnaire, for a total of 508 hours.
An additional 522 mothers are expected
to complete the telephone interview of
20 minutes (0.33 hours) for a total of 172
hours. Sample members who are no
longer a panel member will be asked to
complete a questionnaire to update their
demographic information. An estimated
1,380 participants will return the
demographic questionnaire, which will
require 5 minutes (0.08 hours) to
complete for a total of 110 hours. Thus,
the total estimated burden is 832 hours.
FDA’s burden estimate is based on prior
experience with consumer surveys that
are similar to this proposed data
collection.
PO 00000
Frm 00055
Fmt 4703
Sfmt 9990
II. References
The following reference has been
placed on display in the Division of
Dockets Management (see ADDRESSES)
and may be seen by interested persons
between 9 a.m. and 4 p.m., Monday
through Friday.
1. Fein, Sara B., Judith Labiner-Wolfe,
Katherine Shealy, et al., ‘‘Infant Feeding
Practices Study II: Study Methods,’’
Pediatrics 2008; 122(suppl 2): S28–S35.
Dated: July 7, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011–17676 Filed 7–13–11; 8:45 am]
BILLING CODE 4160–01–P
E:\FR\FM\14JYN1.SGM
14JYN1
]]>Agencies
[Federal Register Volume 76, Number 135 (Thursday, July 14, 2011)]
[Notices]
[Pages 41501-41502]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-17676]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2011-N-0099]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Followup Study for
Infant Feeding Practices Study II
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by August
15, 2011.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX: 202-395-7285, or e-mailed to oira_submission@omb.eop.gov. All
comments should be identified with the OMB control number 0910-New and
title ``Followup Study for Infant Feeding Practices Study II.'' Also
include the FDA docket number found in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT: Denver Presley, Jr., Office of
Information Management, Food and Drug Administration, 1350 Piccard Dr.,
PI50-400B, Rockville, MD 20850, 301-796-3793.
[[Page 41502]]
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Followup Study for Infant Feeding Practices Study II (OMB Control
Number 0910--New)
I. Background
FDA is planning to conduct a survey of the mothers who participated
in the Infant Feeding Practices Study II (IFPS II) (Ref. 1). The IFPS
II sample was drawn from a commercial consumer opinion panel, and so
participants are expected to be easier to re-contact than would be the
case for a random sample of the population. Some participants will
still be panel members. The purpose of the study is to enhance FDA's
understanding of the associations between infant feeding practices and
diet quality, food allergy, overweight and obesity, and other health
and development outcomes in young children.
The study results will be used to help the Agency to understand the
possible role of infant feeding practices in the development and
progression of food allergy and childhood overweight and obesity, in
addition to resistance to infection and other health and development
outcomes. The results of the study will not be used to develop
population estimates.
The data will be collected by a mailed questionnaire from most
respondents and by telephone from those who do not respond to the
mailed questionnaire. The study will focus on the following types of
information: The child's consumption of various food groups; the
child's other consumption practices (such as how often the child eats
dinner with a parent and how often he or she eats from fast food
restaurants); the mother's control over the child's eating patterns;
the child's physical activity and time spent watching a screen (TV or
computer); the child's sleep patterns; extent of the child's cognitive
stimulation at home; the child's height and weight; the child's visits
to a dentist and number of cavities; number of the child's recent
physician visits; number of various types of infections the child had
in the past year; whether the child has various health conditions
including digestive problems, eczema, food allergy, respiratory
allergy, attention deficit disorder, developmental delay, anxiety
problems, depression, or asthma; the child's social development; the
child's family medical history; the mother's height and weight,
physical activity, depression, pregnancies subsequent to the sample
child and whether subsequent children were breastfed, and employment
conditions; the mother's or child's participation in certain government
programs; and the child's potential exposure to certain environmental
contaminants including cigarette smoke and pesticides. Although all
sample members were consumer opinion panel members when the IFPS II was
conducted, many will no longer participate on the panel. Therefore, a
demographic questionnaire will be mailed to respondents who are no
longer a panel member to update current demographic information.
Participation in the study is voluntary.
In the Federal Register of March 1, 2011 (76 FR 11251), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. No comments were received.
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
Portion of study Number of responses per Total annual Average burden per response Total hours
respondents respondent responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
Pilot study mailed questionnaire............ 91 1 91 0.42 (25 minutes)......................... 38
Pilot study telephone interview............. 9 1 9 0.42 (25 minutes)......................... 4
Main study mailed questionnaire............. 1,538 1 1,538 0.33 (20 minutes)......................... 508
Main study telephone interview.............. 522 1 522 0.33 (20 minutes)......................... 172
Demographic questionnaire................... 1,380 1 1,380 0.08 (5 minutes).......................... 110
-----------------------------------------------------------------------------------------------------------
Total................................... .............. .............. .............. .......................................... 832
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
To refine the questionnaire used in the study, a pilot study will
be conducted with 100 participants, 91 by mailed questionnaire and 9 by
telephone interview. We estimate that it will take a respondent 25
minutes (0.42 hours) to complete the survey and debriefing questions by
either method for a total of 38 hours for the mailed and 4 hours for
the interview pretest. The sample for the pilot study will be panel
members who are mothers of 6-year-old children and who did not
participate in the IFPS II.
All IFPS II participants who completed at least two surveys after
their infants were born and for whom current contact information can be
found will be sent the mailed questionnaire. This is expected to be
about 2,562 participants. We estimate that 1,538 respondents will
return it and that it will take an average of 20 minutes (0.33 hours)
to complete the questionnaire, for a total of 508 hours. An additional
522 mothers are expected to complete the telephone interview of 20
minutes (0.33 hours) for a total of 172 hours. Sample members who are
no longer a panel member will be asked to complete a questionnaire to
update their demographic information. An estimated 1,380 participants
will return the demographic questionnaire, which will require 5 minutes
(0.08 hours) to complete for a total of 110 hours. Thus, the total
estimated burden is 832 hours. FDA's burden estimate is based on prior
experience with consumer surveys that are similar to this proposed data
collection.
II. References
The following reference has been placed on display in the Division
of Dockets Management (see ADDRESSES) and may be seen by interested
persons between 9 a.m. and 4 p.m., Monday through Friday.
1. Fein, Sara B., Judith Labiner-Wolfe, Katherine Shealy, et al.,
``Infant Feeding Practices Study II: Study Methods,'' Pediatrics 2008;
122(suppl 2): S28-S35.
Dated: July 7, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-17676 Filed 7-13-11; 8:45 am]
BILLING CODE 4160-01-P
